These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders. Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609 [TBL] [Abstract][Full Text] [Related]
9. bcr/abl-negative, classic myeloproliferative disorders: diagnosis and treatment. Tefferi A; Barbui T Mayo Clin Proc; 2005 Sep; 80(9):1220-32. PubMed ID: 16178503 [TBL] [Abstract][Full Text] [Related]
10. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation]. Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211 [TBL] [Abstract][Full Text] [Related]
11. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia. Michiels JJ Hematol J; 2004; 5(2):93-102. PubMed ID: 15048058 [TBL] [Abstract][Full Text] [Related]
12. [New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene]. Larsen TS; Pallisgaard N; Christensen JH; Gram-Hansen P; Kerndrup GB; Møller MB; Hasselbalch HC Ugeskr Laeger; 2006 Sep; 168(39):3295-9. PubMed ID: 17032591 [TBL] [Abstract][Full Text] [Related]
13. Beyond chronic myelogenous leukemia: potential role for imatinib in Philadelphia-negative myeloproliferative disorders. Cortes J; Kantarjian H Cancer; 2004 May; 100(10):2064-78. PubMed ID: 15139047 [TBL] [Abstract][Full Text] [Related]
14. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management. Tefferi A Am J Hematol; 2013 Jun; 88(6):507-16. PubMed ID: 23695894 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia. Michiels JJ Neth J Med; 1997 Aug; 51(2):57-64. PubMed ID: 9286142 [TBL] [Abstract][Full Text] [Related]